Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07272200

Understanding Gene ENvironment Interaction in ALcohol-related Hepatocellular Carcinoma

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
1,000 (estimated)
Sponsor
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico · Academic / Other
Sex
All
Age
45 Years – 75 Years
Healthy volunteers
Not accepted

Summary

It has been estimated that alcohol causes around 40% of premature liver deaths in Europe each year, although this number is probably underestimated. Alcohol-related liver disease (ALD) is the most common cause of liver cirrhosis and liver death in Europe with a peak age of deaths occurring among individuals aged 40 to 50. Despite these findings, ALD is little studied with only 5% of all clinical trials in the field of liver disease recorded on ClinicalTrials.gov and only 5% of all publications in the same research area. Liver cancer is the second most common cause of cancer-related death (15-20% survival at 5 years) and the second most common cause of alcohol-related cancers worldwide. Like other complex diseases, ALD-HCC results from the interaction between environmental determinants and genetic variations but knowledge of gene-environment interactions is currently lacking in this area. The GENIAL project will address these needs through a comprehensive evaluation of gene-environment interactions concerning ALD-HCC.

Conditions

Interventions

TypeNameDescription
OTHERquantify of risk factorsthe impact of risk factors and their interaction on the incidence of disease through a score that predicts HCC and select patients for whom screening is convenient.

Timeline

Start date
2023-12-01
Primary completion
2026-12-31
Completion
2028-12-31
First posted
2025-12-09
Last updated
2025-12-09

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT07272200. Inclusion in this directory is not an endorsement.

Understanding Gene ENvironment Interaction in ALcohol-related Hepatocellular Carcinoma (NCT07272200) · Clinical Trials Directory